These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32685993)

  • 1. Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer.
    Bortnik S; Tessier-Cloutier B; Leung S; Xu J; Asleh K; Burugu S; Magrill J; Greening K; Derakhshan F; Yip S; Ng T; Gelmon KA; Nielsen TO; Gorski SM
    Breast Cancer Res Treat; 2020 Oct; 183(3):525-547. PubMed ID: 32685993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ATG4 autophagy proteases counteract attachment of ubiquitin-like LC3/GABARAP proteins to other cellular proteins.
    Agrotis A; von Chamier L; Oliver H; Kiso K; Singh T; Ketteler R
    J Biol Chem; 2019 Aug; 294(34):12610-12621. PubMed ID: 31315929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
    Chen S; Jiang YZ; Huang L; Zhou RJ; Yu KD; Liu Y; Shao ZM
    Clin Cancer Res; 2013 Dec; 19(24):6853-62. PubMed ID: 24141623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells.
    Agrotis A; Pengo N; Burden JJ; Ketteler R
    Autophagy; 2019 Jun; 15(6):976-997. PubMed ID: 30661429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LC3B FRET biosensor monitors the modes of action of ATG4B during autophagy in living cells.
    Gökerküçük EB; Cheron A; Tramier M; Bertolin G
    Autophagy; 2023 Aug; 19(8):2275-2295. PubMed ID: 36814061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells.
    Sathiyaseelan P; Chittaranjan S; Kalloger SE; Chan J; Go NE; Jardon MA; Ho CJ; Hui T; Xu J; Chow C; Gao D; Johnson FD; Lockwood WW; Morin GB; Renouf DJ; Schaeffer DF; Gorski SM
    J Cell Sci; 2023 Oct; 136(19):. PubMed ID: 37701987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer.
    Choi J; Jung W; Koo JS
    Histopathology; 2013 Jan; 62(2):275-86. PubMed ID: 23134379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.
    Lefort S; Joffre C; Kieffer Y; Givel AM; Bourachot B; Zago G; Bieche I; Dubois T; Meseure D; Vincent-Salomon A; Camonis J; Mechta-Grigoriou F
    Autophagy; 2014; 10(12):2122-42. PubMed ID: 25427136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATG4B contains a C-terminal LIR motif important for binding and efficient cleavage of mammalian orthologs of yeast Atg8.
    Skytte Rasmussen M; Mouilleron S; Kumar Shrestha B; Wirth M; Lee R; Bowitz Larsen K; Abudu Princely Y; O'Reilly N; Sjøttem E; Tooze SA; Lamark T; Johansen T
    Autophagy; 2017 May; 13(5):834-853. PubMed ID: 28287329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of breast cancer cell subtypes sensitive to ATG4B inhibition.
    Bortnik S; Choutka C; Horlings HM; Leung S; Baker JH; Lebovitz C; Dragowska WH; Go NE; Bally MB; Minchinton AI; Gelmon KA; Gorski SM
    Oncotarget; 2016 Oct; 7(41):66970-66988. PubMed ID: 27556700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cancer associated somatic mutation in LC3B attenuates its binding to E1-like ATG7 protein and subsequent lipidation.
    Nuta GC; Gilad Y; Gershoni M; Sznajderman A; Schlesinger T; Bialik S; Eisenstein M; Pietrokovski S; Kimchi A
    Autophagy; 2019 Mar; 15(3):438-452. PubMed ID: 30238850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.
    Zhao H; Yang M; Zhao J; Wang J; Zhang Y; Zhang Q
    Med Oncol; 2013 Mar; 30(1):475. PubMed ID: 23371253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC3B Binds to the Autophagy Protease ATG4b with High Affinity Using a Bipartite Interface.
    Tang Y; Kay A; Jiang Z; Arkin MR
    Biochemistry; 2022 Nov; 61(21):2295-2302. PubMed ID: 36264309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death.
    Mortezavi A; Salemi S; Rupp NJ; Rüschoff JH; Hermanns T; Poyet C; Randazzo M; Simon HU; Moch H; Sulser T; Wild P; Eberli D
    Oncotarget; 2017 May; 8(19):31765-31774. PubMed ID: 28423666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Expression of Autophagy-Related Marker (LC3B) and Stem Cell Marker (CD44) in Molecular Subtypes of Breast Cancer.
    El-Deek HEM; El-Naggar MS; Sayed SG
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):145-152. PubMed ID: 38285778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of HSP27 and the Autophagy Marker LC3B
    Livingston JA; Wang WL; Tsai JW; Lazar AJ; Leung CH; Lin H; Advani S; Daw N; Santiago-O'Farrill J; Hollomon M; Gordon NB; Kleinerman ES
    Mol Cancer Ther; 2018 Jun; 17(6):1315-1323. PubMed ID: 29592877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.
    Ladoire S; Penault-Llorca F; Senovilla L; Dalban C; Enot D; Locher C; Prada N; Poirier-Colame V; Chaba K; Arnould L; Ghiringhelli F; Fumoleau P; Spielmann M; Delaloge S; Poillot ML; Arveux P; Goubar A; Andre F; Zitvogel L; Kroemer G
    Autophagy; 2015; 11(10):1878-90. PubMed ID: 26506894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.